Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
Sign Up to like & getrecommendations! Published in 2022 at "Human Brain Mapping"
DOI: 10.1002/hbm.26043
Abstract: The A/T/N research framework has been proposed for the diagnosis and prognosis of Alzheimer's disease (AD). However, the spatial distribution of ATN biomarkers and their relationship with cognitive impairment and neuropsychiatric symptoms (NPS) need further… read more here.
Keywords: alzheimer disease; impairment; cognitive impairment; hypometabolism ... See more keywords